NCT00033072

Brief Summary

The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Sep 2001

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2001

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 8, 2002

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2002

Completed
Last Updated

January 11, 2017

Status Verified

November 1, 2003

First QC Date

April 5, 2002

Last Update Submit

January 10, 2017

Conditions

Amphetamine-Related Disorders

Outcome Measures

Primary Outcomes (2)

  • safety of selegiline

  • pharmacokinetic assessment

Interventions

SelegilineDRUG

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteers who meet DSM-4 criteria for methamphetamine abuse or dependence; non-treatment seeking individuals
  • Be able to verbalize understanding of consent form; provide written informed consent

You may not qualify if:

  • Please contact site for more information

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Integrated Substance Abuse Program

Los Angeles, California, 90024, United States

Location

MeSH Terms

Conditions

Amphetamine-Related Disorders

Interventions

Selegiline

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PhenethylaminesEthylaminesAminesOrganic Chemicals

Study Officials

  • Thomas Newton, M.D.

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

April 5, 2002

First Posted

April 8, 2002

Study Start

September 1, 2001

Study Completion

October 1, 2002

Last Updated

January 11, 2017

Record last verified: 2003-11

Locations

US(1)